This is a limited company view. Sign up for a Free Trial to see everything.

Q Holdings engages in the development of human cell-based therapies for the treatment of degenerative diseases of the brain and spinal cord.

B2B
Biotechnology
Healthcare
Pharmaceuticals

Overview

Location

Salt Lake City

Founded

Employees

5

Stage

Series B

Total funding

$12M

Last funding

6 years ago

Acquisitions

0

Growth score

25

Mindshare score

31

Scoring

Employee Growth

Use Q Therapeutics's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Q Therapeutics's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Clinical Program Manager, Associate Scientist

Similar Companies

Angstrom

Angstrom Pharmaceuticals develops new class of drugs targeting CD44 for the treatment of metastatic diseases and hematological malignancies.
Pre-Series A

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes